Federation of Infectious Diseases Societies of Southern Africa guideline: Recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa.
Autor: | Govender NP; National Institute for Communicable Diseases, Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses, Division of the National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Avenant T; Kalafong Provincial Tertiary Hospital and Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Brink A; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Ampath Laboratories, Cape Town, South Africa., Chibabhai V; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; National Health Laboratory Service, Johannesburg, South Africa.; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa., Cleghorn J; Life Healthcare Group, Johannesburg, South Africa., du Toit B; Mediclinic Southern Africa, Cape Town, South Africa., Govind C; Lancet Laboratories, Durban, South Africa., Lewis E; Steve Biko Pretoria Academic Hospital, Pretoria, South Africa., Lowman W; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; WITS Donald Gordon Medical Centre and Vermaak and Partners Pathologists, Johannesburg, South Africa., Mahlangu H; Clinix Health Group, Johannesburg, South Africa., Maslo C; Netcare Hospitals Limited, Johannesburg, South Africa., Messina A; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Netcare Hospitals Limited, Johannesburg, South Africa., Mer M; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa., Pieton K; Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa., Seetharam S; Lancet Laboratories, Cape Town, South Africa., Sriruttan C; National Institute for Communicable Diseases [Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses], a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Swart K; Netcare Hospitals Limited, Johannesburg, South Africa., van Schalkwyk E; National Institute for Communicable Diseases [Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses], a Division of the National Health Laboratory Service, Johannesburg, South Africa. |
---|---|
Jazyk: | angličtina |
Zdroj: | Southern African journal of infectious diseases [S Afr J Infect Dis] 2019 Sep 26; Vol. 34 (1), pp. 163. Date of Electronic Publication: 2019 Sep 26 (Print Publication: 2019). |
DOI: | 10.4102/sajid.v34i1.163 |
Abstrakt: | Candida auris has been detected at almost 100 South African hospitals, causing large outbreaks in some facilities, and this pathogen now accounts for approximately 1 in 10 cases of candidaemia. The objective of this guideline is to provide updated, evidence-informed recommendations outlining a best-practice approach to prevent, diagnose and manage C. auris disease in public- and private-sector healthcare settings in South Africa. The 18 practical recommendations cover five focus areas: laboratory identification and antifungal susceptibility testing, surveillance and outbreak response, infection prevention and control, clinical management and antifungal stewardship. Competing Interests: All members of the guideline development group completed an International Committee of Medical Journal Editors (ICMJE) conflicts of interest form. Over the past 36 months, Adrian Brink served on speakers’ bureaus for Merck, Sharp & Dohm (MSD) South Africa and Pfizer. Warren Lowman received speaker fees from MSD South Africa, Pfizer and Astellas. Charlotte Sriruttan received a travel grant from MSD South Africa. For all other authors, no conflicts of interest were declared. (© 2019. The Authors.) |
Databáze: | MEDLINE |
Externí odkaz: |